Asia-Pacific Biotech 1 article

Asia-Pacific Biotech covers biotechnology ecosystems across the region outside the dedicated China section, including companies, financing, clinical development, manufacturing, licensing and regulatory environments. Cross-country comparisons are useful when they reveal different paths to commercialization or research scale across markets such as Japan, South Korea, Singapore and Australia. China-centered asset licensing stays in its own category so this section can represent the wider regional landscape.